Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Screening and treatment of infections caused by resistant enterococci.

Literature DB >> 2024952

Screening and treatment of infections caused by resistant enterococci.

D J Herman¹, D N Gerding.

Abstract

Entities: Disease

Mesh：

Year: 1991 PMID： 2024952 PMCID： PMC244979 DOI： 10.1128/AAC.35.2.215

Source DB: PubMed Journal: Antimicrob Agents Chemother ISSN： 0066-4804 Impact factor: 5.191

× No keyword cloud information.

68 in total

1. Influence of gentamicin dose size on the efficacies of combinations of gentamicin and penicillin in experimental streptomycin-resistant enterococcal endocarditis.

Authors: A J Wright; W R Wilson; J Y Matsumoto; J A Washington; J E Geraci
Journal: Antimicrob Agents Chemother Date: 1982-12 Impact factor: 5.191

2. Synergy of penicillin and decreasing concentration of aminoglycosides against enterococci from patients with infective endocarditis.

Authors: J Y Matsumoto; W R Wilson; A J Wright; J E Geraci; J A Washington
Journal: Antimicrob Agents Chemother Date: 1980-12 Impact factor: 5.191

3. Treatment of streptomycin-susceptible and streptomycin-resistant enterococcal endocarditis.

Authors: W R Wilson; C J Wilkowske; A J Wright; M A Sande; J E Geraci
Journal: Ann Intern Med Date: 1984-06 Impact factor: 25.391

4. Imipenem therapy of experimental Staphylococcus aureus and Streptococcus faecalis endocarditis.

Authors: W M Scheld; J M Keeley
Journal: J Antimicrob Chemother Date: 1983-12 Impact factor: 5.790

5. Plasmid-mediated resistance to aminocyclitol antibiotics in group D streptococci.

Authors: P Courvalin; C Carlier; E Collatz
Journal: J Bacteriol Date: 1980-08 Impact factor: 3.490

6. Therapeutic potential of rifampin in enterococcal infections.

Authors: R C Moellering; C Wennersten
Journal: Rev Infect Dis Date: 1983 Jul-Aug

7. Susceptibility of enterococci and Listeria monocytogenes to N-Formimidoyl thienamycin alone and in combination with an aminoglycoside.

Authors: G M Eliopoulos; R C Moellering
Journal: Antimicrob Agents Chemother Date: 1981-05 Impact factor: 5.191

8. Enterococci. Biologic and epidemiologic characteristics and in vitro susceptibility.

Authors: D Kaye
Journal: Arch Intern Med Date: 1982-10-25

9. Methodological variation in antibiotic synergy tests against enterococci.

Authors: R W Ryan; I Kwasnik; R C Tilton
Journal: J Clin Microbiol Date: 1981-01 Impact factor: 5.948

10. Retrospective study of the toxicity of preparations of vancomycin from 1974 to 1981.

Authors: B F Farber; R C Moellering
Journal: Antimicrob Agents Chemother Date: 1983-01 Impact factor: 5.191

12 in total

Review 1. Vancomycin-resistant enterococci.

Authors: Y Cetinkaya; P Falk; C G Mayhall
Journal: Clin Microbiol Rev Date: 2000-10 Impact factor: 26.132

10. Overproduction of a penicillin-binding protein is not the only mechanism of penicillin resistance in Enterococcus faecium.

Authors: I Klare; A C Rodloff; J Wagner; W Witte; R Hakenbeck
Journal: Antimicrob Agents Chemother Date: 1992-04 Impact factor: 5.191

Screening and treatment of infections caused by resistant enterococci.

1. Influence of gentamicin dose size on the efficacies of combinations of gentamicin and penicillin in experimental streptomycin-resistant enterococcal endocarditis.

2. Synergy of penicillin and decreasing concentration of aminoglycosides against enterococci from patients with infective endocarditis.

3. Treatment of streptomycin-susceptible and streptomycin-resistant enterococcal endocarditis.

4. Imipenem therapy of experimental Staphylococcus aureus and Streptococcus faecalis endocarditis.

5. Plasmid-mediated resistance to aminocyclitol antibiotics in group D streptococci.

6. Therapeutic potential of rifampin in enterococcal infections.

7. Susceptibility of enterococci and Listeria monocytogenes to N-Formimidoyl thienamycin alone and in combination with an aminoglycoside.

8. Enterococci. Biologic and epidemiologic characteristics and in vitro susceptibility.

9. Methodological variation in antibiotic synergy tests against enterococci.

10. Retrospective study of the toxicity of preparations of vancomycin from 1974 to 1981.

Review 1. Vancomycin-resistant enterococci.

Review 2. Current perspectives on glycopeptide resistance.

3. Resistant enterococci--mechanisms, laboratory detection and control in hospitals.

4. Novel antibiotic regimens against Enterococcus faecium resistant to ampicillin, vancomycin, and gentamicin.

5. Gastrointestinal tract colonization with vancomycin-resistant Enterococcus faecium in an animal model.

6. Detection of vancomycin resistance in Enterococcus species.

Review 7. Anti-infective treatment in intensive care: the role of glycopeptides.

8. Recovery of vancomycin-resistant gram-positive cocci from pediatric liver transplant recipients.

Review 9. Infections due to antibiotic-resistant gram-positive cocci.

10. Overproduction of a penicillin-binding protein is not the only mechanism of penicillin resistance in Enterococcus faecium.